We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Inspire Medical Systems Inc (INSP) Com USD0.001

Sell:$241.14 Buy:$241.15 Change: $1.29 (0.53%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$241.14
Buy:$241.15
Change: $1.29 (0.53%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
Sell:$241.14
Buy:$241.15
Change: $1.29 (0.53%)
Market closed |  Prices as at close on 18 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.

Contact details

Address:
5500 Wayzata Blvd Ste 1600
GOLDEN VALLEY
55416-1237
United States
Telephone:
+1 (763) 9575037
Website:
https://www.inspiresleep.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
INSP
ISIN:
US4577301090
Market cap:
$6.71 billion
Shares in issue:
30.30 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Timothy Herbert
    President, Chief Executive Officer, Director
  • Richard Buchholz
    Chief Financial Officer
  • Philip Ebeling
    Chief Operating Officer
  • Bryan Phillips
    Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
  • John Rondoni
    Chief Technology Officer
  • Steven Jandrich
    Vice President of Human Resources
  • Randall Ban
    Chief Commercial Officer
  • Charisse Sparks
    Chief Medical Officer
  • Carlton Weatherby
    Chief Strategy Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.